Independent and incremental role of quantitative right ventricular evaluation for the prediction of right ventricular failure after left ventricular assist device implantation.

PubWeight™: 3.17‹?› | Rank: Top 1%

🔗 View Article (PMID 22858287)

Published in J Am Coll Cardiol on August 07, 2012

Authors

Andrew D M Grant1, Nicholas G Smedira, Randall C Starling, Thomas H Marwick

Author Affiliations

1: Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA.

Articles citing this

Right heart failure post left ventricular assist device implantation. J Thorac Dis (2014) 1.37

Assessment and treatment of right ventricular failure. Nat Rev Cardiol (2013) 1.22

Straining with the ventricular assist device and right ventricular function. J Am Coll Cardiol (2012) 1.07

Use of Heart Failure Medical Therapies Among Patients With Left Ventricular Assist Devices: Insights From INTERMACS. J Card Fail (2016) 0.81

Assessment of right ventricular function in left ventricular assist device candidates. Circ Cardiovasc Imaging (2014) 0.81

Influence of positive end-expiratory pressure on myocardial strain assessed by speckle tracking echocardiography in mechanically ventilated patients. Biomed Res Int (2013) 0.81

Serial echocardiography using tissue Doppler and speckle tracking imaging to monitor right ventricular failure before and after left ventricular assist device surgery. JACC Heart Fail (2013) 0.81

Predictors of right ventricular failure after left ventricular assist device implantation. Croat Med J (2014) 0.80

A UK Single Centre Retrospective Analysis of the Relationship between Haemodynamic Changes and Outcome in Patients Undergoing Prolonged Left Ventricular Assist Device Support. Ann Thorac Cardiovasc Surg (2014) 0.79

Predictors and management of right heart failure after left ventricular assist device implantation. Methodist Debakey Cardiovasc J (2015) 0.79

Right ventricular strain as a novel approach to analyze right ventricular performance in patients with heart failure. Heart Fail Rev (2014) 0.78

Management and outcome of patients supported with Impella 5.0 for refractory cardiogenic shock. Crit Care (2015) 0.78

The Right Ventricular Function After Left Ventricular Assist Device (RVF-LVAD) study: rationale and preliminary results. Eur Heart J Cardiovasc Imaging (2015) 0.77

Model for end-stage liver disease predicts right ventricular failure in patients with left ventricular assist devices. J Artif Organs (2015) 0.77

Medical management of patients with continuous-flow left ventricular assist devices. Curr Treat Options Cardiovasc Med (2014) 0.76

Role of strain imaging in right heart disease: a comprehensive review. J Clin Med Res (2014) 0.76

Right ventricular afterload sensitivity dramatically increases after left ventricular assist device implantation: A multi-center hemodynamic analysis. J Heart Lung Transplant (2016) 0.75

The right prediction. J Am Coll Cardiol (2012) 0.75

Biventricular VAD versus LVAD for right heart failure. Ann Cardiothorac Surg (2014) 0.75

Right Ventricular Longitudinal Strain Is Depressed in a Bovine Model of Pulmonary Hypertension. Anesth Analg (2016) 0.75

The future of left ventricular assist devices. J Thorac Dis (2015) 0.75

A Bayesian Model to Predict Right Ventricular Failure Following Left Ventricular Assist Device Therapy. JACC Heart Fail (2016) 0.75

Right ventricular free wall strain: a predictor of successful left ventricular assist device implantation. Tex Heart Inst J (2015) 0.75

Diagnosing and treating the failing right heart. Curr Opin Cardiol (2015) 0.75

Echocardiographic linear fractional shortening for quantification of right ventricular systolic function-A cardiac magnetic resonance validation study. Echocardiography (2017) 0.75

Reply: To PMID 22858287. J Am Coll Cardiol (2012) 0.75

Echocardiographic assessment for ventricular assist device placement. J Thorac Dis (2015) 0.75

Mid-term survival after continuous-flow left ventricular assist device versus heart transplantation. Heart Vessels (2015) 0.75

Systematic Left Ventricular Assist Device Implant Eligibility with Non-Invasive Assessment: The SIENA Protocol. J Cardiovasc Ultrasound (2017) 0.75

Articles by these authors

HFSA 2010 Comprehensive Heart Failure Practice Guideline. J Card Fail (2010) 6.37

Unexpected abrupt increase in left ventricular assist device thrombosis. N Engl J Med (2013) 6.33

Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol (2009) 5.76

The prognostic value of a nomogram for exercise capacity in women. N Engl J Med (2005) 5.03

Gene-expression profiling for rejection surveillance after cardiac transplantation. N Engl J Med (2010) 4.31

Plasma B-type natriuretic peptide levels in ambulatory patients with established chronic symptomatic systolic heart failure. Circulation (2003) 4.25

Radial artery bypass grafts have an increased occurrence of angiographically severe stenosis and occlusion compared with left internal mammary arteries and saphenous vein grafts. Circulation (2004) 4.13

Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant (2010) 4.00

Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardiol (2004) 3.87

Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev (2004) 3.69

Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N Engl J Med (2003) 3.61

Tissue Doppler imaging a new prognosticator for cardiovascular diseases. J Am Coll Cardiol (2007) 3.41

Prediction of all-cause mortality from global longitudinal speckle strain: comparison with ejection fraction and wall motion scoring. Circ Cardiovasc Imaging (2009) 3.06

Effects of perioperative nesiritide in patients with left ventricular dysfunction undergoing cardiac surgery:the NAPA Trial. J Am Coll Cardiol (2006) 2.88

The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. J Am Coll Cardiol (2007) 2.82

Exercise training for patients with heart failure: a systematic review of factors that improve mortality and morbidity. Am J Med (2004) 2.81

Global 2-dimensional strain as a new prognosticator in patients with heart failure. J Am Coll Cardiol (2009) 2.77

Patients with early diabetic heart disease demonstrate a normal myocardial response to dobutamine. J Am Coll Cardiol (2003) 2.76

Cardiorenal outcomes after slow continuous ultrafiltration therapy in refractory patients with advanced decompensated heart failure. J Am Coll Cardiol (2012) 2.75

Mitral valve surgery in heart failure: insights from the Acorn Clinical Trial. J Thorac Cardiovasc Surg (2006) 2.62

Investigation of a novel algorithm for synchronized left-ventricular pacing and ambulatory optimization of cardiac resynchronization therapy: results of the adaptive CRT trial. Heart Rhythm (2012) 2.60

The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation (2007) 2.50

Clinical, imaging, and pathological characteristics of left ventricular thrombus: a comparison of contrast-enhanced magnetic resonance imaging, transthoracic echocardiography, and transesophageal echocardiography with surgical or pathological validation. Am Heart J (2006) 2.48

Sodium nitroprusside for advanced low-output heart failure. J Am Coll Cardiol (2008) 2.47

EAE/ASE recommendations for image acquisition and display using three-dimensional echocardiography. J Am Soc Echocardiogr (2012) 2.41

Alterations of left ventricular myocardial characteristics associated with obesity. Circulation (2004) 2.41

Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis. JACC Cardiovasc Imaging (2009) 2.41

Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group. Circulation (2007) 2.34

Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: analysis of 245 patients. Circulation (2002) 2.33

The relative importance of vascular structure and function in predicting cardiovascular events. J Am Coll Cardiol (2004) 2.32

Effect of If-channel inhibition on hemodynamic status and exercise tolerance in heart failure with preserved ejection fraction: a randomized trial. J Am Coll Cardiol (2013) 2.24

Are all readmissions bad readmissions? N Engl J Med (2010) 2.22

Reproducibility and accuracy of echocardiographic measurements of left ventricular parameters using real-time three-dimensional echocardiography. J Am Coll Cardiol (2004) 2.21

Normal ranges of left ventricular strain: a meta-analysis. J Am Soc Echocardiogr (2012) 2.17

The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. Eur Heart J (2007) 2.14

Clinical and demographic predictors of outcomes in recent onset dilated cardiomyopathy: results of the IMAC (Intervention in Myocarditis and Acute Cardiomyopathy)-2 study. J Am Coll Cardiol (2011) 2.10

Exercise testing in asymptomatic patients after revascularization: are outcomes altered? Arch Intern Med (2012) 2.10

Outcomes of patients with peripartum cardiomyopathy who received mechanical circulatory support. Data from the Interagency Registry for Mechanically Assisted Circulatory Support. Circ Heart Fail (2014) 2.09

Influence of patient characteristics and arterial grafts on freedom from coronary reoperation. J Thorac Cardiovasc Surg (2005) 2.09

Does off-pump coronary surgery reduce morbidity and mortality? J Thorac Cardiovasc Surg (2002) 2.08

Left ventricular dyssynchrony predicts benefit of cardiac resynchronization therapy in patients with end-stage heart failure before pacemaker implantation. Am J Cardiol (2003) 2.08

Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy. J Am Coll Cardiol (2012) 2.07

Exercise training for type 2 diabetes mellitus: impact on cardiovascular risk: a scientific statement from the American Heart Association. Circulation (2009) 2.06

Residual high incidence of ventricular arrhythmias after left ventricular reconstructive surgery. J Thorac Cardiovasc Surg (2005) 2.03

A comparison of bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: the EVOLUTION-ON study. J Thorac Cardiovasc Surg (2006) 2.00

Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease: Consensus statement from the Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart Association. Circulation (2005) 1.97

International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010. J Heart Lung Transplant (2010) 1.97

Elevated intra-abdominal pressure in acute decompensated heart failure: a potential contributor to worsening renal function? J Am Coll Cardiol (2008) 1.87

Insights from a cardiac resynchronization optimization clinic as part of a heart failure disease management program. J Am Coll Cardiol (2009) 1.86

Association of subclinical right ventricular dysfunction with obesity. J Am Coll Cardiol (2006) 1.81

Real-time 3D echocardiographic quantification of left atrial volume: multicenter study for validation with CMR. JACC Cardiovasc Imaging (2012) 1.74

Prediction of hospital outcome in septic shock: a prospective comparison of tissue Doppler and cardiac biomarkers. Crit Care (2010) 1.73

Association of imaging markers of myocardial fibrosis with metabolic and functional disturbances in early diabetic cardiomyopathy. Circ Cardiovasc Imaging (2011) 1.73

Prevalence of heart failure and systolic ventricular dysfunction in older Australians: the Canberra Heart Study. Med J Aust (2006) 1.72

A gatekeeper for the gatekeeper: inappropriate referrals to stress echocardiography. Am Heart J (2007) 1.71

Predictors of long-term outcomes in symptomatic hypertrophic obstructive cardiomyopathy patients undergoing surgical relief of left ventricular outflow tract obstruction. Circulation (2013) 1.71

Cardioprotective effect of β-adrenoceptor blockade in patients with breast cancer undergoing chemotherapy: follow-up study of heart failure. Circ Heart Fail (2013) 1.70

Effects of nesiritide and predictors of urine output in acute decompensated heart failure: results from ASCEND-HF (acute study of clinical effectiveness of nesiritide and decompensated heart failure). J Am Coll Cardiol (2013) 1.70

Relationship of ventricular longitudinal function to contractile reserve in patients with mitral regurgitation. Am Heart J (2003) 1.69

Impact of gender on risk stratification by exercise and dobutamine stress echocardiography: long-term mortality in 4234 women and 6898 men. Eur Heart J (2005) 1.68

Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I. J Clin Endocrinol Metab (2005) 1.68

Why all the focus on cardiac imaging? JACC Cardiovasc Imaging (2010) 1.68

A putative placebo analysis of the effects of LCZ696 on clinical outcomes in heart failure. Eur Heart J (2015) 1.68

Daclizumab to prevent rejection after cardiac transplantation. N Engl J Med (2005) 1.67

Early risk of mortality after coronary artery revascularization in patients with left ventricular dysfunction and potential role of the wearable cardioverter defibrillator. Circ Arrhythm Electrophysiol (2012) 1.66

Pulmonary-vein isolation for atrial fibrillation in patients with heart failure. N Engl J Med (2008) 1.65

Mitral valve abnormalities in hypertrophic cardiomyopathy: echocardiographic features and surgical outcomes. Ann Thorac Surg (2008) 1.65

Echocardiographic detection of early diabetic myocardial disease. J Am Coll Cardiol (2003) 1.65

A randomized study of the beneficial effects of aldosterone antagonism on LV function, structure, and fibrosis markers in metabolic syndrome. JACC Cardiovasc Imaging (2011) 1.65

Effect of statin therapy on the risk for incident heart failure in patients with breast cancer receiving anthracycline chemotherapy: an observational clinical cohort study. J Am Coll Cardiol (2012) 1.65

Tissue Doppler in critical illness: a retrospective cohort study. Crit Care (2007) 1.65

Cardiac dimensions are largely determined by dietary salt in patients with primary aldosteronism: results of a case-control study. J Clin Endocrinol Metab (2011) 1.64

Persistent hemodynamic benefits of cardiac resynchronization therapy with disease progression in advanced heart failure. J Am Coll Cardiol (2009) 1.64

Neurohormonal response to left ventricular reconstruction surgery in ischemic cardiomyopathy. J Thorac Cardiovasc Surg (2004) 1.63

Importance of treadmill exercise time as an initial prognostic screening tool in patients with systolic left ventricular dysfunction. Circulation (2009) 1.63

Association of cardiac autonomic neuropathy with subclinical myocardial dysfunction in type 2 diabetes. JACC Cardiovasc Imaging (2010) 1.62

Contribution of exercise echocardiography to the diagnosis of heart failure with preserved ejection fraction (HFpEF). Heart (2010) 1.60

Surgery for permanent atrial fibrillation: impact of patient factors and lesion set. Ann Thorac Surg (2006) 1.59

Intravascular ultrasound evidence of angiographically silent progression in coronary atherosclerosis predicts long-term morbidity and mortality after cardiac transplantation. J Am Coll Cardiol (2005) 1.59

Independent association of left atrial function with exercise capacity in patients with preserved ejection fraction. Heart (2012) 1.58

Identification of therapeutic benefit from revascularization in patients with left ventricular systolic dysfunction: inducible ischemia versus hibernating myocardium. Circ Cardiovasc Imaging (2013) 1.58

Effect of aldosterone antagonism on myocardial dysfunction in hypertensive patients with diastolic heart failure. Circulation (2004) 1.57

Management of the waiting list for cadaveric kidney transplants: report of a survey and recommendations by the Clinical Practice Guidelines Committee of the American Society of Transplantation. J Am Soc Nephrol (2002) 1.57

Diastolic stress echocardiography: hemodynamic validation and clinical significance of estimation of ventricular filling pressure with exercise. J Am Coll Cardiol (2006) 1.57

Assessment of dyspnea in acute decompensated heart failure: insights from ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure) on the contributions of peak expiratory flow. J Am Coll Cardiol (2012) 1.56

Randomized trial of guiding hypertension management using central aortic blood pressure compared with best-practice care: principal findings of the BP GUIDE study. Hypertension (2013) 1.56

Major bleeding during HeartMate II support. J Am Coll Cardiol (2013) 1.55

Left ventricular mechanical dyssynchrony in acute onset cardiomyopathy: association of its resolution with improvements in ventricular function. JACC Cardiovasc Imaging (2011) 1.54

Bivalirudin during cardiopulmonary bypass in patients with previous or acute heparin-induced thrombocytopenia and heparin antibodies: results of the CHOOSE-ON trial. Ann Thorac Surg (2007) 1.53

Usefulness of immunosuppression for giant cell myocarditis. Am J Cardiol (2008) 1.52

Incremental cost-effectiveness of exercise echocardiography vs. SPECT imaging for the evaluation of stable chest pain. Eur Heart J (2006) 1.51

Impact of aortic valve replacement on outcome of symptomatic patients with severe aortic stenosis with low gradient and preserved left ventricular ejection fraction. Circulation (2013) 1.51

Patients with a hypertensive response to exercise have impaired systolic function without diastolic dysfunction or left ventricular hypertrophy. J Am Coll Cardiol (2004) 1.50

The impact of left ventricular reconstruction on survival in patients with ischemic cardiomyopathy. Eur J Cardiothorac Surg (2006) 1.50

Association of masked hypertension and left ventricular remodeling with the hypertensive response to exercise. Am J Hypertens (2011) 1.50

Outcomes of simultaneous liver transplantation and elective cardiac surgical procedures. Ann Thorac Surg (2011) 1.49

Myocardial ischemic-fibrotic injury after human heart transplantation is associated with increased progression of vasculopathy, decreased cellular rejection and poor long-term outcome. J Am Coll Cardiol (2002) 1.47

Prognostic implications of left ventricular filling pressure with exercise. Circ Cardiovasc Imaging (2010) 1.47

Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. Heart (2012) 1.46